Back to today’s briefing

Story perspectives

CMV Boosts Melanoma Treatment, Reduces Side Effects

4/25/2025

32 4

Summary

Story summary

Oxford University scientists have made a groundbreaking discovery: the common cytomegalovirus (CMV) may boost melanoma treatment effectiveness while minimizing side effects. In a study of 341 patients undergoing immunotherapy, those with CMV showed improved responses to PD-1 monotherapy and faced fewer complications. Researchers are eager to delve deeper into CMV's promising role in cancer therapy across the UK.

1 of 1

Story summary

Oxford University scientists have made a groundbreaking discovery: the common cytomegalovirus (CMV) may boost melanoma treatment effectiveness while minimizing side effects. In a study of 341 patients undergoing immunotherapy, those with CMV showed improved responses to PD-1 monotherapy and faced fewer complications. Researchers are eager to delve deeper into CMV's promising role in cancer therapy across the UK.